Tissue Tech Inc. Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Miami FL United States (2001)

Organization Overview

First Clinical Trial
2011
NCT03113786
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Tissue Tech Inc.

Active Ingredients

Drugs in Phase 4 Trials (1)

amniotic membrane (1 trial)

Drugs in Phase 2 Trials (1)

ttax03 (1 trial)

Drugs in Phase 1 Trials (1)

terpinen-4-ol (1 trial)

Drugs in Other Trials (3)

amniotic and umbilical cord matrix (1 trial)

clarix flo (1 trial)

lifitegrast (xiidra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blepharitis (Phase 1)

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Leg Ulcer (Phase 2)

Ulcer (Phase 3)

Varicose Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6